Received Mar 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | — |
The patient took two doses of Vivotif capsules at the same time instead of one dose; The patient took two doses of Vivotif capsules at the same time instead of one dose; Case reference number US-BN-2024-002757 is a spontaneous case initially received from consumer via Med Communications (reference number: USBAV24-2945) on 07-Nov-2024 and concerns a male patient of unknown age. The patient's medical history and concomitant medication details were not provided. On 07-Nov-2024, reported as today, the patient took the first and second of Vivotif capsule at the same time instead of one dose (batch number: unknown), at a dose of one capsule, via unknown route and for unknown indication (explicitly coded as 'vaccine overdose' and 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20241107-f50cae to US-BAVARIAN NORDIC A/S-US-BN-2024-002757, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A male patient of unknown age took the first and the second of Vivotif capsule at the same time instead of one dose for unknown indication, which is considered as vaccine overdose and inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to Vivotif. Overdose and inappropriate schedule of product administration are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Overdose and inappropriate schedule of product administration are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A male patient of unknown age took the first and the second of Vivotif capsule at the same time instead of one dose for unknown indication, which is considered as vaccine overdose and inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to Vivotif. Overdose and inappropriate schedule of product administration are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Overdose and inappropriate schedule of product administration are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None